Laddar...
RAAS inhibitors do not increase the risk of COVID-19
According to five new studies, therapy with angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) is not associated with an increased risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or with an increased risk of severe disease or in...
Sparad:
| I publikationen: | Nat Rev Cardiol |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group UK
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7243952/ https://ncbi.nlm.nih.gov/pubmed/32444693 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41569-020-0401-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|